New nasal vaccine aims to protect kids from RSV
Vaccine
Recruiting now
This study tests a new nasal spray vaccine (BLB-201) to prevent RSV, a common virus that can cause serious breathing problems in young children. About 137 infants and children aged 8 to 59 months will receive either the vaccine or a placebo. The goal is to check if the vaccine is…
Phase 1/2 • Sponsor: Blue Lake Biotechnology Inc. • Aim: Vaccine
Last updated Jul 31, 2026 00:00 UTC